Status:
COMPLETED
Assessing the Impact of an Educational HIV Prevention Intervention in Zambia
Lead Sponsor:
Columbia University
Collaborating Sponsors:
German Development Corporation
American Institutes for Research
Conditions:
HIV/AIDS
Eligibility:
All Genders
14-22 years
Phase:
NA
Brief Summary
In Zambia, 13% of the 15 to 49 year old population lives with HIV. The highest number of new HIV infections is among young people. To counter the spread of the disease, developmental and governmental ...
Detailed Description
The study's population is schools in the Choma and Livingstone provinces of Zambia (a final set of 170 schools). The schools were provided by the Zambian Ministry of Education. The schools are split b...
Eligibility Criteria
Inclusion
- Students must be enrolled in the selected grade in one of the study schools and present on the day of the interview (for piloting) or on the day of baseline and endline (for main evaluation)
- Students must have informed consent
- Students must speak English or Tonga
Exclusion
- There are no exclusion criteria within the pre-defined schools
Key Trial Info
Start Date :
March 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2017
Estimated Enrollment :
8270 Patients enrolled
Trial Details
Trial ID
NCT03316040
Start Date
March 16 2017
End Date
December 2 2017
Last Update
January 31 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10027
2
American Institutes for Research
Choma, Zambia
3
American Institutes for Research
Livingstone, Zambia